Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1089)
Edgewise Therapeutics, Inc. (EWTX)
Donovan Joanne M. — CMO
Shares
9,623
Price
$30.98
Total Value
$298.10K
Shares Held After
16,332
% of Holdings
37.1%
LENZ Therapeutics, Inc. (LENZ)
Chevallard Daniel R. — Chief Financial Officer
Shares
7,500
Price
$8.57
Total Value
$64.28K
Shares Held After
12,886
% of Holdings
58.2%
LENZ Therapeutics, Inc. (LENZ)
George Jeffrey P. — Director
Shares
5,592
Price
$8.92
Total Value
$49.89K
Shares Held After
5,592
% of Holdings
100.0%
LENZ Therapeutics, Inc. (LENZ)
Schimmelpennink Evert B. — Director
Shares
28,089
Price
$8.95
Total Value
$251.41K
Shares Held After
77,289
% of Holdings
36.3%
ANAPTYSBIO, INC (ANAB)
Faga Daniel — Director
Shares
100
Price
$65.99
Total Value
$6.60K
Shares Held After
495,965
% of Holdings
0.0%
ANAPTYSBIO, INC (ANAB)
Faga Daniel — Director
Shares
3,038
Price
$65.20
Total Value
$198.07K
Shares Held After
496,065
% of Holdings
0.6%
ANAPTYSBIO, INC (ANAB)
Faga Daniel — Director
Shares
3,155
Price
$64.19
Total Value
$202.52K
Shares Held After
499,103
% of Holdings
0.6%
ANAPTYSBIO, INC (ANAB)
Faga Daniel — Director
Shares
2,592
Price
$63.35
Total Value
$164.20K
Shares Held After
502,258
% of Holdings
0.5%
ANAPTYSBIO, INC (ANAB)
Faga Daniel — Director
Shares
1,012
Price
$62.15
Total Value
$62.90K
Shares Held After
504,850
% of Holdings
0.2%
ANAPTYSBIO, INC (ANAB)
Faga Daniel — Director
Shares
550
Price
$60.63
Total Value
$33.34K
Shares Held After
505,862
% of Holdings
0.1%
ANAPTYSBIO, INC (ANAB)
Faga Daniel — Director
Shares
490
Price
$59.62
Total Value
$29.22K
Shares Held After
506,412
% of Holdings
0.1%
ANAPTYSBIO, INC (ANAB)
Faga Daniel — Director
Shares
3,662
Price
$58.62
Total Value
$214.65K
Shares Held After
506,902
% of Holdings
0.7%
ANAPTYSBIO, INC (ANAB)
Faga Daniel — Director
Shares
2,570
Price
$57.91
Total Value
$148.82K
Shares Held After
510,564
% of Holdings
0.5%
ANAPTYSBIO, INC (ANAB)
Faga Daniel — Director
Shares
510
Price
$56.61
Total Value
$28.87K
Shares Held After
513,134
% of Holdings
0.1%
Roivant Sciences Ltd. (ROIV)
Fitzgerald Meghan — Director
Shares
70,000
Price
$27.45
Total Value
$1.92M
Shares Held After
42,963
% of Holdings
62.0%
Wave Life Sciences Ltd. (WVE)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
351,224
Price
$6.38
Total Value
$2.24M
Shares Held After
23,508,791
% of Holdings
1.5%
Wave Life Sciences Ltd. (WVE)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
4,954,558
Price
$6.06
Total Value
$30.02M
Shares Held After
23,157,567
% of Holdings
21.4%
COMPUGEN LTD (CGEN)
Levine Zurit — SVP, Business Development
Shares
11,875
Price
$2.04
Total Value
$24.19K
Shares Held After
29,375
% of Holdings
28.8%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
2,803
Price
$99.46
Total Value
$278.79K
Shares Held After
59,634
% of Holdings
4.5%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
1,757
Price
$98.21
Total Value
$172.55K
Shares Held After
62,437
% of Holdings
2.7%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
940
Price
$97.50
Total Value
$91.65K
Shares Held After
64,194
% of Holdings
1.4%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
7,684
Price
$37.22
Total Value
$285.99K
Shares Held After
2,251,485
% of Holdings
0.3%
Neurogene Inc. (NGNE)
Jordan Julie — Chief Medical Officer
Shares
828
Price
$21.89
Total Value
$18.13K
Shares Held After
12,472
% of Holdings
6.2%
Neurogene Inc. (NGNE)
McMinn Rachel — Director
Shares
3,352
Price
$22.07
Total Value
$74.00K
Shares Held After
1,344,307
% of Holdings
0.2%
Neurogene Inc. (NGNE)
Cvijic Christine Mikail — President and CFO
Shares
2,558
Price
$21.62
Total Value
$55.32K
Shares Held After
103,240
% of Holdings
2.4%
Xilio Therapeutics, Inc. (XLO)
Shannon James Samuel — Director
Shares
5,000
Price
$8.79
Total Value
$43.95K
Shares Held After
10,000
% of Holdings
50.0%
Silexion Therapeutics Corp (SLXN)
Shirvan Mitchell — CSO and CDO
Shares
22,818
Price
$1.36
Total Value
$31.03K
Shares Held After
27,889
% of Holdings
45.0%
CYPHERPUNK TECHNOLOGIES INC. (CYPH)
Mirabelli Christopher — Director
Shares
60,000
Price
$0.71
Total Value
$42.63K
Shares Held After
130,376
% of Holdings
31.5%
Protagonist Therapeutics, Inc (PTGX)
MOLINA ARTURO MD — Chief Medical Officer
Shares
15,000
Price
$104.79
Total Value
$1.57M
Shares Held After
84,115
% of Holdings
15.1%
Protagonist Therapeutics, Inc (PTGX)
SELICK HAROLD E — Director
Shares
24,000
Price
$105.00
Total Value
$2.52M
Shares Held After
60,845
% of Holdings
28.3%
Protagonist Therapeutics, Inc (PTGX)
Ali Asif — Chief Financial Officer
Shares
24,765
Price
$104.24
Total Value
$2.58M
Shares Held After
60,753
% of Holdings
29.0%
Centessa Pharmaceuticals plc (CNTA)
Anderson Karen M. — Chief People Officer
Shares
41,076
Price
$30.12
Total Value
$1.24M
Shares Held After
62,085
% of Holdings
39.8%
KalVista Pharmaceuticals, Inc. (KALV)
Venrock Healthcare Capital Partners III, L.P. — 10% Owner
Shares
3,183
Price
$19.12
Total Value
$60.86K
Shares Held After
5,089,354
% of Holdings
0.1%
KalVista Pharmaceuticals, Inc. (KALV)
Venrock Healthcare Capital Partners III, L.P. — 10% Owner
Shares
15,417
Price
$18.82
Total Value
$290.15K
Shares Held After
5,092,537
% of Holdings
0.3%
KalVista Pharmaceuticals, Inc. (KALV)
Venrock Healthcare Capital Partners III, L.P. — 10% Owner
Shares
21,386
Price
$17.76
Total Value
$379.82K
Shares Held After
5,107,954
% of Holdings
0.4%
iBio, Inc. (IBIO)
Banjak Marc — Chief Legal Officer
Shares
1,434
Price
$1.76
Total Value
$2.52K
Shares Held After
25,000
% of Holdings
5.7%
iBio, Inc. (IBIO)
Banjak Marc — Chief Legal Officer
Shares
12,500
Price
$1.64
Total Value
$20.53K
Shares Held After
23,566
% of Holdings
53.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
320
Price
$540.04
Total Value
$172.81K
Shares Held After
18,876
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
994
Price
$538.91
Total Value
$535.68K
Shares Held After
19,196
% of Holdings
4.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,149
Price
$537.90
Total Value
$618.05K
Shares Held After
20,190
% of Holdings
5.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,577
Price
$536.90
Total Value
$846.69K
Shares Held After
21,339
% of Holdings
6.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,003
Price
$535.94
Total Value
$1.07M
Shares Held After
22,916
% of Holdings
8.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,847
Price
$534.98
Total Value
$988.10K
Shares Held After
24,919
% of Holdings
6.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
609
Price
$533.91
Total Value
$325.15K
Shares Held After
26,766
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
510
Price
$532.93
Total Value
$271.79K
Shares Held After
27,375
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
991
Price
$532.02
Total Value
$527.24K
Shares Held After
27,885
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$539.98
Total Value
$151.19K
Shares Held After
40,513
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
740
Price
$538.90
Total Value
$398.79K
Shares Held After
40,793
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,100
Price
$537.97
Total Value
$591.77K
Shares Held After
41,533
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,540
Price
$536.96
Total Value
$826.91K
Shares Held After
42,633
% of Holdings
3.5%
Showing 101–150 of 1089 transactions (page 3 of 22)